Daniel Skovronsky, EVP, CSO & Pres. LRL & LLY Imm at Eli Lilly & Co, holds 213.28K shares in Eli Lilly & Co (Ticker: LLY), holds 135.81K shares in Myriad Genetics (Ticker: MYGN). Most recently, Daniel Skovronsky Bought ― shares of Eli Lilly & Co on Aug 12, 2025 for an estimated value of $634.40K.
What is the percentage of profitable transactions made by Daniel Skovronsky?
The percentage of profitable transactions made by Daniel Skovronsky is 100%.
What is the average return per transaction made by Daniel Skovronsky?
The average return per transaction made by Daniel Skovronsky is 25.40%.
What stocks does Daniel Skovronsky hold?
Daniel Skovronsky holds: LLY, MYGN stocks.
What was Daniel Skovronsky’s latest transaction?
Daniel Skovronsky latest transaction was an Informative Buy of $634.40K.
What was Daniel Skovronsky's most profitable transaction?
Daniel Skovronsky’s most profitable transaction was an Informative Buy of LLY stock on June 14, 2018. The return on the trade was 32.20%.
What is Daniel Skovronsky's role in Eli Lilly & Co?
Daniel Skovronsky's role in Eli Lilly & Co is EVP, CSO & Pres. LRL & LLY Imm.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.